News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,057 Results
Type
Article (63)
Company Profile (1)
Press Release (993)
Section
Business (282)
Deals (31)
Drug Delivery (1)
Drug Development (173)
FDA (24)
Job Trends (12)
News (515)
Policy (49)
Tag
Academia (3)
Alliances (75)
ALS (1)
Approvals (25)
Artificial intelligence (2)
Autoimmune disease (3)
Best Places to Work (10)
Biotechnology (1)
Breast cancer (1)
Cancer (5)
Cardiovascular disease (4)
CAR-T (1)
Cell therapy (3)
Clinical research (153)
Collaboration (5)
COVID-19 (4)
C-suite (2)
Cystic fibrosis (1)
Data (12)
Diagnostics (22)
Duchenne muscular dystrophy (1)
Earnings (116)
Events (136)
Executive appointments (8)
FDA (28)
Funding (5)
Government (4)
Guidances (1)
Healthcare (24)
Immunology and inflammation (5)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (14)
Job creations (3)
JPM (1)
Legal (3)
Machine learning (1)
Manufacturing (1)
Medical device (2)
Medtech (2)
Mergers & acquisitions (22)
Neurodegenerative disease (1)
Neuropsychiatric disorders (1)
Neuroscience (2)
NextGen: Class of 2026 (7)
Non-profit (14)
Opinion (1)
Pancreatic cancer (1)
Partnered (1)
People (94)
Phase 1 (23)
Phase 2 (66)
Phase 3 (74)
Pipeline (15)
Postmarket research (5)
Preclinical (11)
Rare diseases (8)
Real estate (5)
Regulatory (47)
Research institute (4)
Series B (1)
Sickle cell disease (1)
Startups (9)
Vaccines (3)
Venture capital (2)
Date
Today (1)
Last 7 days (1)
Last 30 days (3)
Last 365 days (74)
2026 (6)
2025 (75)
2024 (55)
2023 (74)
2022 (59)
2021 (37)
2020 (54)
2019 (56)
2018 (37)
2017 (59)
2016 (49)
2015 (83)
2014 (48)
2013 (52)
2012 (54)
2011 (67)
2010 (67)
Location
Asia (27)
Australia (5)
California (13)
Canada (4)
China (2)
Connecticut (4)
Europe (108)
Florida (3)
Georgia (14)
Illinois (1)
Indiana (1)
Maryland (12)
Massachusetts (15)
Michigan (1)
Nevada (2)
New Jersey (7)
North Carolina (3)
Northern California (6)
Oklahoma (1)
Pennsylvania (1)
South America (3)
Southern California (4)
Texas (12)
United States (86)
Washington D.C. (1)
Washington State (1)
1,057 Results for "odyssey therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Odyssey Therapeutics Appoints Jolie M. Siegel as Executive Vice President, General Counsel
January 21, 2026
·
3 min read
IPO
Odyssey Ends Quest for Nasdaq, Pulls IPO Application After Nearly 5 Months
Odyssey filed for an IPO in January but never revealed a fundraising target.
June 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace
October 17, 2025
·
5 min read
Press Releases
Odyssey Therapeutics Appoints Dennis Dean, Ph.D., as Executive Vice President, Head of Non-Clinical Development
November 11, 2025
·
3 min read
Funding
Odyssey Rebounds Off Failed IPO With $213M Series D
The autoimmune and inflammatory disease–focused company canceled plans to go public earlier this year as the IPO window slammed shut.
September 10, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors
October 10, 2025
·
2 min read
Press Releases
Odyssey Therapeutics Announces Oversubscribed $213 Million Series D Financing to Advance Clinical Pipeline for Autoimmune Diseases
September 11, 2025
·
5 min read
Press Releases
Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial
April 14, 2025
·
15 min read
Partnered
Ending the Diagnostic Odyssey for Patients
Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients’ quality of life while reducing costs to healthcare systems.
December 11, 2024
·
4 min read
·
BioSpace Insights
Press Releases
Odyssey Therapeutics Appoints Jason Haas as Chief Financial Officer
January 8, 2025
·
3 min read
1 of 106
Next
